World Drug targets Summit
|Event Date/Time: Jul 20, 2011||End Date/Time: Jul 21, 2011|
|Early Registration Date: Apr 01, 2011|
How do you generate commercially differentiated products? Identify disease-modifying targets that will result in valuable therapeutic compounds?
These are some of the questions that leading drug developers Pfizer, UCB Pharma, Bayer and Merck amongst others are debating, and will form the backbone of the World Drug Targets Summit agenda. This cutting edge meeting will provide a great blend of senior executives and scientists from pharma/biotech companies and the foremost academics in the field to discuss different target identification and validation strategies.
Whatâ€™s covered on the agenda?
â€¢ Learn how to predict the market potential of a novel drug target
â€¢ Discuss novel tools and methods to approach target discovery
â€¢ Explore target identification strategies for key therapeutic areas
â€¢ Review the strategic decision-making process for target validation
â€¢ Discover how to demonstrate adequate proof of concept in the clinic
â€¢ Consider the optimal strategies to go after undruggable targets
â€¢ Gain detailed insights into the importance of synergistic collaborations within industry
â€¢ Probe into the structure of drug targets and druggable hot spots
Early Bird discounts still apply! Simply quote: ACC in order to receive the best possible rates!
For more information or to register, simply:
Call: +1 212 537 5898